Articles Published in 2011

ACRO endorses Foreign Earnings Reinvestment Act

Wednesday, October 12, 2011 10:10 AM

The Association of Clinical Research Organizations (ACRO) supports the Foreign Earnings Reinvestment Act, bipartisan legislation introduced in the U.S. Senate last week by senators Kay Hagan (D-NC) and John McCain (R-AZ).

More... »

Cleave Biosciences raises $42 million in Series A financing

Tuesday, October 11, 2011 02:39 PM

Cleave Biosciences, a newly established biopharmaceutical company discovering and developing novel therapies for cancer, has raised $42 million in Series A financing.

More... »

Exonhit, Pfizer collaborate in Alzheimer’s research

Tuesday, October 11, 2011 02:26 PM

Exonhit has entered into a research agreement with Pfizer for the identification of new Alzheimer's disease biomarkers using Exonhit's Genome-Wide SpliceArray (GWSA) platform.

More... »

Researchers use RNA technology to block inflammation

Tuesday, October 11, 2011 01:26 PM

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication in Nature Biotechnology, the investigators describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage.

More... »

PAREXEL Academy expands to Singapore

Tuesday, October 11, 2011 01:11 PM

PAREXEL Academy, a provider of education and professional training for the biopharmaceutical industry in the field of clinical research, which is operated by PAREXEL International, has entered into an agreement with the National University of Singapore (NUS), through its National University of Singapore Academy of GxP Excellence (NUSAGE), to offer an academic program in Singapore to help meet the increasing demand for talent in the field of clinical research in the Asia region. This demand is being driven by the growing complexity and globalization of biopharmaceutical research and development.

More... »

MediSapiens, Bayer HealthCare collaborate in oncology

Tuesday, October 11, 2011 01:01 PM

MediSapiens and Bayer HealthCare Pharmaceuticals have agreed to develop a platform for genomics data management and analysis in oncology.

More... »

FDA approves Fluoxetine 60mg tablets

Tuesday, October 11, 2011 12:55 PM

Edgemont Pharmaceuticals has reported that the FDA has approved its New Drug Application (NDA) for Fluoxetine tablets 60 mg.

More... »

BioNanomatrix changes name to BioNano Genomics

Tuesday, October 11, 2011 12:48 PM

BioNanomatrix has changed its name to BioNano Genomics.  By adopting the new name, the company is communicating its position as a solution provider for genomics researchers who want to fully understand the biology of the genomes at the core of their research.  The change follows the recent establishment of new corporate headquarters in San Diego, the appointment of new leadership, and additional new investment.

More... »

StudyManager launches Reveal 3.3

Tuesday, October 11, 2011 12:41 PM

StudyManager, a provider of clinical trial management software (CTMS) and electronic data capture (EDC) solutions, has released Reveal 3.3, with enhanced features that provide greater ease of use and performance for research sites, academic medical centers, and hospitals.

More... »

Biotron’s phase IIa Hepatitis C study shows positive results

Tuesday, October 11, 2011 12:29 PM

Australian drug development company Biotron has released results from its phase IIa trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients.

More... »